JPRN-UMIN000032901招募中4 期
The investigation of safety and efficacy of short hydration GC therapy in metastatic urothelial carcinoma patients - The investigation of safety and efficacy of short hydration GC therapy
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 10 人开始时间: 2018年6月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients who had allergy in gemcitabine 2. patients who had allergy in cisplatin 3. previously treated patients by gemcitabine, or cisplatin 4. patients who had sign of interstitial pneumoniae or pulmonary fibrosis 5. patients previously treated in chest by radiation therapy 6. patients who have infection or fever 7. pregnant patients 8. patients giving lactation 9. patients including severe diseases 10. unadequate patients
研究者
相似试验
尚未招募
3 期
Evaluation of the Safety and Efficacy of Short-term A 002 Treatment in Subjects with Acute Coronary SyndromesHeart AttackHeart Disease10082206NL-OMON34504Anthera Pharmaceuticals, Inc576
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-CZAnthera Pharmaceuticals, Inc.6,504
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-DEAnthera Pharmaceuticals, Inc.6,504
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes (VISTA-16) - VISTA-16Acute Coronary SyndromesMedDRA version: 9.1Level: LLTClassification code 10051592EUCTR2009-016812-18-ITANTHERA PHARMACEUTICALS6,504
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-HUAnthera Pharmaceuticals, Inc.6,504